Perioperative administration of beta-blockers;Perioperative betablockade (CME 4/02)

Anasthesiologie und Intensivmedizin

Volumn 43, Issue 4, 2002, Pages 223-235

  Tonner, Peter H ^a   Brockhoff, C ^a   Paris, A ^a   Scholz, J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Adrenergic Receptor Antagonists; Beta Blockers; Myocardial Infarction; Myocardial Ischaemia; Premedication

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LABETALOL;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFICACY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; PATHOPHYSIOLOGY; PEROPERATIVE CARE; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; RISK MANAGEMENT; SURGICAL RISK;

EID: 0036332820     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Anästhesiologische aspekte des kardialen risikopatienten bei extrakardialen eingriffen
2. Kardioprotektion in der perioperativen phase bei nichtkardialen eingriffen
3. Perioperative cardiac morbidity
4. Multifactorial index of cardiac risk in noncardiac surgical procedures
5. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index
6. Clinical Guidelines Part I: Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery
7. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery
8. Multifactorial index of cardiac risk in noncardiac surgical procedures
9. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery
10. The Study of Perioperative Ischemia Research Group: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery
11. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery
12. The Study of Perioperative Ischemia Research Group: Long-term cardiac prognosis following noncardiac surgery
13. Perioperative ischemia and cardiac complications in major vascular surgery: Importance of the preoperative twelve-lead electrocardiogram
14. The Study of Perioperative Ischemia (SPI) Research Group: Perioperative myocardial ischemia in patients undergoing noncardiac surgery-I: Incidence and severi ty during the 4 day perioperative period
15. Perioperative myocardial ischemia in patients undergoing elective hip arthroplasty during lumbar regional anesthesia
16. Perioperative myocardial infarction and cardiac complications after noncardiac surgery in patients with prior myocardial infarction. I. Clinical data and diagnosis, incidence
17. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?
18. Myocardial ischemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent
19. Locoregional versus general anesthesia in carotid surgery: Is there an impact on perioperative myocardial ischemia? Results of a prospective monocentric randomized trial
20. Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia
21. Perioperative myocardial ischemia in patients undergoing noncardiac surgery-II: Incidence and severity during the 1st week after surgery
22. Preoperative assessment of the patient with cardiac disease
23. Prophylactic atenolol reduces postoperative myocardial ischemia
24. Perioperative catecholamine changes in cardiac risk patients
25. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery
26. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade
27. Pathology of fatal perioperative myocardial infarction: Implication regarding pathophysiology and prevention
28. Strategies to achieve coronary arterial plaque stabilization
29. Effect of timolol on late ventricular arrhythmias after acute myocardial infarction
30. Heart rate as a therapeutic target in heart failure
31. Hospital admission blood pressure: A predictor for hypertension following endotracheal intubation
32. Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery
33. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS 1
34. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
35. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
36. Continuous propranolol infusion following abdominal surgery
37. Perioperative beta-blockade with propranolol: Reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias
38. Should we all have a sympathectomy at birth? Or at least preoperatively?
39. The Multicenter Study of Perioperative Ischemia Research Group: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery
40. Prophylactic therapy of perioperative myocardial ischemia
41. Peri-operative beta-blockade: A useful treatment that should be greeted with cautious enthusiasm
42. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery
43. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
44. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography
45. Reducing cardiac risk in noncardiac surgery
46. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy
47. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia
48. Myocardial ischemia during noncardiac surgical procedures in patients with coronary artery disease
49. Myocardial ischemia and adverse cardiac outcomes in cardiac patients undergoing noncardiac surgery with sevoflurane and isoflurane
50. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery
51. Preoperative risk assessment: Many studies, few solutions. Is a cardiac risk assessment paradigm possible?
52. Negative impact of cardiac evaluation before vascular surgery
53. Noncardiac surgery in the cardiac patient: What is the question?
54. Prophylactic coronary artery revascularization for elective vascular surgery: Study design
55. Beta-adrenergic receptor blockade in chronic heart failure
56. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
57. Beta-adrenergic-blocking drugs: Incredibly useful, incredibly underutilized
58. Secondary prevention of myocardial infarction: Role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors
59. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting
60. Kardiovaskuläre stressprotektion während der anästhesieeinleitung
61. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: The European Mivazerol Trial (EMIT)
62. Pre-anaesthetic administration of alpha2-adrenoceptor agonists
63. Regional anaesthesia in patients at coronary risk for noncardiac and cardiac surgery